By Stefania Spada
Biopharmaceuticals, the time period for genetically engineered healing proteins, monoclonal antibodies, and nucleic acid-based items, became an expanding a part of the pharmaceutical armament. whereas this type of substances debts for about 25% of all new medicinal drugs coming to marketplace, only a few references exist that evaluate those commercially to be had items. beforehand, getting access to info at the checklist of at present authorized biopharmaceuticals has been exhausting and patchy.
Directory of authorized Biopharmaceutical items brings jointly key details on numerous elements of those compounds, offering a quick precis of every biopharmaceutical presently authorized for clinical use. each one precis comprises the medical and alternate identify, 12 months and areas authorized, licensed symptoms, producer, advertising and marketing correct, approach to manufacture, clinical assessment, and healing homes. according to details amassed from regulatory corporations and pharmaceutical brands, the e-book offers the main finished information at the moment to be had in one, handy volume.
This accomplished and constant method will retailer pros within the pharmaceutical hours spent trawling the literature - and gives a unique source for destiny reference.
Read Online or Download Directory of Approved Biopharmaceutical Products PDF
Best toxicology books
In Vitro tools in Pharmaceutical study offers a accomplished consultant to laboratory strategies for comparing in vitro organ toxicity utilizing mobile types. step by step functional how to practice and interpret assays for drug metabolism and toxicity evaluation are supplied, in addition to a comparability of alternative ideas on hand.
The main depended on all-in-one assessment of the biomedical and environmental facets of toxicology--NOW extra whole, up to date, and in complete colorA Doody's middle name for 2015! NEW to the 8th variation FULL-COLOR layout to permit for a clearer interpretationof the fundamental parts of toxicology featured during the textual content extended tables, illustrations, and different visuals areupdated with state of the art criteria that makes thisedition much more present and correct DVD with photo financial institution good points all tables and illustrations from the textual content in presentation-ready structure NEW CHAPTERS comprise "Toxic results of Calories"and "Toxic results of Nanoparticles"The world's best and so much authoritative textbook on poisons has extra to supply students,toxicologists, and pharmacologists than ever prior to.
This ebook describes in attention-grabbing aspect the range of experiments subsidized by way of the U. S. govt during which human matters have been uncovered to radiation, frequently with out their wisdom or consent. in accordance with a assessment of thousands of heretofore unavailable or labeled records, this record tells a gripping tale of the tricky dating among technology and the kingdom.
The IACUC Administrator’s consultant to Animal application administration helps IACUC administrators who assist with constructing, dealing with, and overseeing a application of animal care and animal use. It offers many innovations and probabilities for particular operational practices (e. g. , the right way to construct a well-functioning IACUC, what a sensible protocol template seems like) to fulfill regulatory standards.
- Introduction to Food Toxicology
- Current Protocols in Toxicology
- Statistical Methods for QTL Mapping
- Compendium of Trace Metals and Marine Biota: Volume 2: Vertebrates
Additional info for Directory of Approved Biopharmaceutical Products
The shelf life of the product is 18 months when stored at 2 to 8°C. Routine evaluative tests are carried out on the final product to ensure its quality and safety. Overview of Therapeutic Properties Multiple sclerosis (MS) is a chronic, disabling disease of the central nervous system. In the benign form (15% of cases) no disabilities occur, whereas primary progressive MS (10 to 15% of cases) brings minor loss of function. The majority of patients (70%) suffer from relapsing-remitting and secondary progressive disease and develop significant disabilities — either gradually or due to the relapsing-remitting, which involves a worsening of the disease followed by partial or complete recovery.
Oncol. , 6, 12–16, 2002. , Rasburicase: a potent uricolytic agent, Expert Opin. , 3, 433–452, 2002. H. , Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma, J. Clin. , 19, 697–704, 2001.
Opin. , 15(5), 363–370, 2003. Blum, K. , Antibodies for the treatment of diffue large cell lymphoma, Semin. , 30(4), 448–456, 2003. M. , Binding to CD 20 by anti-B1 antibody or F (ab) (2) is sufficient for induction of apoptosis in B cell lines, Cancer Immunol. , 51(1), 15–24, 2002. W. , Retention of B-cell specific monoclonal antibodies by human lymphoma cells, Blood, 83, 1390–1397, 1994. S. ) is a recombinant human growth hormone (hGH, somatropin). 1-kDa, 191-amino acid, single-chain polypeptide is produced in a modified Escherichia coli strain using recombinant DNA technology.